Home
Madison Avenue Partners reported a 2.7% stake in Keros Therapeutics KROS · 823,707 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 2.7%
- Last report
- 6.4% · filed 25/05/14
- Shares held
- 823,707 sh
- Class
- Common Stock, $0.0001 par value per share (the "Common Stock")
- Holder
- Madison Avenue Partners
- Event date
- 25/12/31
- Filed
- 26/02/17
2.7% stake · below 5%
- Stake
- 2.7%
- Last report
- 6.4%
- Since last report
- −3.7pp
Keros Therapeutics trades, last 26 weeks
What else happened in Keros Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Madison Avenue Partners's other 5% stake reports
- Madison Avenue Partners
5% stakeGraham Holdings
5% stakeGraham Holdings
GHC
7.5% stake
246,368 sh
7.5% stake
Filed 08/14
- Madison Avenue Partners
5% stakeStaar Surgical
5% stakeStaar Surgical
STAA
8.4% stake
4,175,748 sh
8.4% stake
Filed 08/14
- Madison Avenue Partners
5% stakeLakefront Biotherapeutics
5% stakeLakefront Biotherapeutics
LKFT
5.5% stake
3,606,203 sh
5.5% stake
Filed 06/23
- Madison Avenue Partners
5% stakeMagnera
5% stakeMagnera
MAGN
4.4% stake
1,590,616 sh
4.4% stake
Filed 05/15
- Madison Avenue Partners
5% stakeIndivior Pharmaceuticals
5% stakeIndivior Pharmaceuticals
INDV
3.5% stake
4,315,162 sh
3.5% stake
Filed 05/15
